Latest FDA Stories
DALLAS, March 2, 2015 /PRNewswire/ -- ReportsnReports.com adds Lonsurf and Avastin (Colorectal Cancer) - Forecast and Market Analysis to 2023 research report focuses on
-- First BLA submission for an investigational reversal agent for a novel oral anticoagulant RIDGEFIELD, Conn., March 2, 2015 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
Cure of keratoconus and restoring vision has been of paramount importance to Khanna Vision Institute.
The Software and Cybersecurity Risk Management for Medical Device conference — chaired by internationally renowned expert Fubin Wu — has been specifically designed to provide attendees with
Stay up-to-date on key medical device regulation changes with the most authoritative and comprehensive guide ever assembled.
Mesothelioma lawyers of The Law Office of Melinda J. Helbock A.P.C.
On February 24, 2015, Harper’s Bazaar Magazine’s website posted an article reporting on the development of a topical form of botulinum toxin type A. Dr.
SHANGHAI, Feb. 27, 2015 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc.
FALLS CHURCH, Va., Feb.
- LILETTA(TM) Offers Women Broad Access to Safe, Effective Long-Term Contraception through Groundbreaking Company Partnership - DUBLIN and SAN FRANCISCO, Feb.